Literature DB >> 14724210

Opioid receptor stimulation suppresses the adrenal medulla hypoxic response in sheep by actions on Ca(2+) and K(+) channels.

Damien J Keating1, Grigori Y Rychkov, Michael B Adams, Hans Holgert, I Caroline McMillen, Michael L Roberts.   

Abstract

Before the preganglionic regulation of the adrenal medulla is established, hypoxia acts directly on the chromaffin cells to evoke the secretion of catecholamines. This direct action of hypoxia is suppressed by the gradual development of the preganglionic innervation and we have proposed that opioid peptides released from the adrenal splanchnic nerves may be responsible for this suppression. The effects of the specific opioid agonists DPDPE (delta-agonist), U-62066 (kappa-agonist) and DALDA (mu-agonist) on the hypoxia-evoked response were investigated in both a whole-gland preparation and in isolated adrenal chromaffin cells using amperometry, whole-cell patch clamping and measurement of cytosolic [Ca(2+)]. The combined application of mu- and kappa-type agonists abolished the hypoxia-evoked catecholamine secretion from whole perfused adrenal gland. In isolated chromaffin cells, mu- and kappa-opioid agonists reduced the rise in [Ca(2+)](i) that results from exposure to hypoxia. Both agonists decreased the voltage-dependent Ca(2+) current in these cells. The mu-agonist increased the conductance through SK-type K(+) channels and this action offset the decrease in K(+) conductance produced by exposure to hypoxia. The kappa-type agonist decreased the conductance through an action on BK-type K(+) channels, a class of channels that are not involved in initiating the direct response to hypoxia. These data suggest that opioids, through their action on SK channels and voltage-dependent Ca(2+) channels, may be responsible for the nerve-induced suppression of the hypoxic response of adrenal chromaffin cells and that these effects of endogenous opioids are mediated via mu- and kappa-type receptors.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14724210      PMCID: PMC1664836          DOI: 10.1113/jphysiol.2003.056176

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  33 in total

1.  Neonatal adaptation: naloxone increases the catecholamine surge at birth.

Authors:  J F Padbury; Y Agata; D H Polk; D L Wang; C C Callegari
Journal:  Pediatr Res       Date:  1987-06       Impact factor: 3.756

2.  Mu and kappa opioids inhibit transmitter release by different mechanisms.

Authors:  E Cherubini; R A North
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

3.  Single residue modifications of the delta opioid receptor selective peptide, [D-Pen2,D-Pen5]-enkephalin (DPDPE). Correlation of pharmacological effects with structural and conformational features.

Authors:  R C Haaseth; K Sobczyk-Kojiro; F Medzihradsky; C B Smith; H I Mosberg
Journal:  Int J Pept Protein Res       Date:  1990-08

Review 4.  Oxygen sensing by the carotid body chemoreceptors.

Authors:  N R Prabhakar
Journal:  J Appl Physiol (1985)       Date:  2000-06

5.  Naloxone potentiates epinephrine release during hypoxia in fetal sheep: dose response and cardiovascular effects.

Authors:  A Martinez; J Padbury; L Shames; C Evans; J Humme
Journal:  Pediatr Res       Date:  1988-04       Impact factor: 3.756

6.  Vasoactive intestinal polypeptide stimulates the secretion of catecholamines from the rat adrenal gland.

Authors:  R K Malhotra; A R Wakade
Journal:  J Physiol       Date:  1987-07       Impact factor: 5.182

7.  Ontogeny of adrenomedullary responses to hypoxia and hypoglycemia: role of splanchnic innervation.

Authors:  F J Seidler; T A Slotkin
Journal:  Brain Res Bull       Date:  1986-01       Impact factor: 4.077

8.  Inhibition by opioid agonists and enhancement by antagonists of the release of catecholamines from the dog adrenal gland in response to splanchnic nerve stimulation: evidence for the functional role of opioid receptors.

Authors:  T Kimura; M Katoh; S Satoh
Journal:  J Pharmacol Exp Ther       Date:  1988-03       Impact factor: 4.030

9.  The distribution of opioid binding subtypes in the bovine adrenal medulla.

Authors:  S J Bunn; P D Marley; B G Livett
Journal:  Neuroscience       Date:  1988-12       Impact factor: 3.590

10.  Fetal adrenal medulla catecholamine response to hypoxia-direct and neural components.

Authors:  C Y Cheung
Journal:  Am J Physiol       Date:  1990-06
View more
  8 in total

Review 1.  Protecting motor networks during perinatal ischemia: the case for delta-opioid receptors.

Authors:  Stephen M Johnson; Sara M F Turner
Journal:  Ann N Y Acad Sci       Date:  2010-06       Impact factor: 5.691

2.  Chronic exposure of neonatal rat adrenomedullary chromaffin cells to opioids in vitro blunts both hypoxia and hypercapnia chemosensitivity.

Authors:  Shaima Salman; Josef Buttigieg; Min Zhang; Colin A Nurse
Journal:  J Physiol       Date:  2012-11-12       Impact factor: 5.182

3.  Catecholamine secretion from rat foetal adrenal chromaffin cells and hypoxia sensitivity.

Authors:  R Bournaud; J Hidalgo; H Yu; E Girard; T Shimahara
Journal:  Pflugers Arch       Date:  2006-12-13       Impact factor: 3.657

4.  Developmental changes of chromaffin cell secretory response to hypoxia studied in thin adrenal slices.

Authors:  María García-Fernández; Rebeca Mejías; José López-Barneo
Journal:  Pflugers Arch       Date:  2006-12-13       Impact factor: 3.657

5.  Developmental change of T-type Ca2+ channel expression and its role in rat chromaffin cell responsiveness to acute hypoxia.

Authors:  Konstantin L Levitsky; José López-Barneo
Journal:  J Physiol       Date:  2009-03-09       Impact factor: 5.182

6.  Microbiota Modulate Anxiety-Like Behavior and Endocrine Abnormalities in Hypothalamic-Pituitary-Adrenal Axis.

Authors:  Ran Huo; Benhua Zeng; Li Zeng; Ke Cheng; Bo Li; Yuanyuan Luo; Haiyang Wang; Chanjuan Zhou; Liang Fang; Wenxia Li; Rong Niu; Hong Wei; Peng Xie
Journal:  Front Cell Infect Microbiol       Date:  2017-11-30       Impact factor: 5.293

Review 7.  From Pharmacology to Physiology: Endocrine Functions of μ-Opioid Receptor Networks.

Authors:  Nikolai Jaschke; Sophie Pählig; Ying-Xian Pan; Lorenz C Hofbauer; Andy Göbel; Tilman D Rachner
Journal:  Trends Endocrinol Metab       Date:  2021-03-03       Impact factor: 12.015

Review 8.  From gut dysbiosis to altered brain function and mental illness: mechanisms and pathways.

Authors:  G B Rogers; D J Keating; R L Young; M-L Wong; J Licinio; S Wesselingh
Journal:  Mol Psychiatry       Date:  2016-04-19       Impact factor: 15.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.